Healome Therapeutics
PrivateLast Round
Seed
Jul 7, 2026
Total Funding Raised
$3.03M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Healome Therapeutics operates in Healthcare & Life Sciences and is based in Birmingham. Its latest recorded funding round was a Seed round in July 2026.
Healome Therapeutics is a United Kingdom-based ophthalmology company developing a platform eye-drop matrix technology for ocular surface diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healome Therapeutics Comparables
Compare Healome Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaliq | 73% | |
| Stuart Therapeutics, Inc. | 66% | |
| Ripple Therapeutics | 64% |
For institutional investors. Book with your work email.
Healome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 7, 2026 | ||||
| Pre Seed | Apr 27, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Healome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oshen Holdings SA | Seed |
| Empirical Ventures | Seed |
| Innovate UK | Pre Seed |
| SFC Capital | Pre Seed, Seed |
| DEBRA Research gGmbH | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
$2.68M round led by Empirical Ventures.
- Apr 27, 2022
$532K round with SFC Capital and Innovate UK
For institutional investors. Book with your work email.
Healome Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Healome Therapeutics's valuation, stock price, and market status.
Is Healome Therapeutics a public or private company?
Healome Therapeutics is a private company.
What is the current stock price of Healome Therapeutics?
Healome Therapeutics is a private company, so its shares have no public market price. Caplight tracks Healome Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Healome Therapeutics worth (valuation)?
Valuation information for Healome Therapeutics is not publicly available.
Can I buy Healome Therapeutics stock?
Healome Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Healome Therapeutics's last funding round?
Healome Therapeutics's most recent funding round was Seed on July 7, 2026.
Who are the main investors in Healome Therapeutics?
Key investors in Healome Therapeutics include Empirical Ventures.
Will Healome Therapeutics IPO soon?
No public IPO plans have been announced for Healome Therapeutics.
How can I track Healome Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Healome Therapeutics's shares on secondary markets.